Advertisement

Latest News

Recent Oral Therapy Developments in Psoriasis, With April W. Armstrong, MD, MPH

1 hour ago

Armstrong’s interview highlights oral therapies in the psoriasis treatment space highlighted in her session at the 2026 AAD meeting.

First-Generation Gene Editing in Sickle Cell Faces Real-World Limits Despite Breakthrough Results

3 hours ago

Asthma Controllers Safe in First Trimester, With Anick Bérard, PhD

4 hours ago

In an interview, Bérard discusses population-based data showing no increased risk of major congenital malformations with first-trimester asthma controller use.

Clinical Ethics Consultation in Practice, With Aliza Narva, JD, MSN

8 hours ago

In a Q&A with Dominic Sisti, Narva discusses ethics consult workflows, common conflicts, and lessons from complex ICU cases.

Ravulizumab Reduces Proteinuria as Early as Week 10 in Phase 3 I CAN Trial for IgAN

10 hours ago

Ravulizumab reduced proteinuria by week 10 and met the primary endpoint in the phase 3 I CAN trial in IgA nephropathy.

Advertisement
Advertisement